SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is facing intense community polarization, with persistent criticism regarding its long-term price performance and leadership transparency contrasting against a dedicated base of "diamond-handed" investors who view current price levels as a strategic accumulation opportunity. While detractors highlight comparisons to other trending tokens and label the project a scam due to the lack of immediate price action, supporters continue to anchor their thesis on institutional developments like the Coinbase 50 inclusion and the belief that the project's utility and regulatory compliance will drive value in the coming years.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Delta Air Lines is capturing investor attention as record-breaking holiday travel demand clashes with operational pressures, including government-linked disruptions and ongoing weather-related flight delays. Traders are actively debating the sustainability of current price levels, while the stock continues to see heavy call option activity and institutional interest focused on the carrier's premium positioning in a K-shaped economy.

Bank of Montreal engages in the provision of banking and financial services to individuals and institutions. It operates through the following segments: Canadian Personal and Commercial Banking (Canadian P&C), United States Personal and Commercial Banking (U.S. P&C), BMO Wealth Management, BMO Capital Markets, and Corporate Services. The company was founded by Robert Armour, John C. Bush, Austin Cuvillier, George Garden, Horatio Gates, James Leslie, George Moffatt, John Richardson and Thomas A. Turner on June 23, 1817 and is headquartered in Toronto, Canada.

Bank of Montreal - MicroSectors Gold Miners 3X Leveraged ETN

GDXU is experiencing heightened volatility and intense community discussion following a significant pullback from recent highs, driven by shifting macroeconomic narratives and rapid price fluctuations in gold. While some traders view the current levels as a generational buying opportunity due to long-term safe-haven tailwinds, others are cautious of the 3x leverage risk, emphasizing that price discovery remains erratic as investors debate the sustainability of the current metals bull trend.

Hyperliquid is a performant L1 optimized from the ground up. The vision is a fully onchain open financial system with user built applications interfacing with performant native components, all without compromising end user experience.   The Hyperliquid L1 is performant enough to operate an entire ecosystem of permissionless financial applications – every order, cancel, trade, and liquidation happens transparently on-chain with block latency &lt;1 second. The chain currently supports 100k orders / second.  The Hyperliquid L1 uses a custom consensus algorithm called HyperBFT which is heavily inspired by Hotstuff and its successors. Both the algorithm and networking stack are optimized from the ground up to support the L1.   The flagship native application is a fully onchain order book perpetuals exchange, the Hyperliquid DEX. Further developments include a native token standard, spot trading, permissionless liquidity, etc.

Hype

Hyperliquid ($HYPE) is capturing significant attention as traders debate its long-term utility versus competitors like Aster and Avantis, while community discussions remain split between those bullish on its deflationary tokenomics and others wary of upcoming token unlocks. The conversation is heavily focused on HYPEs role as a dominant decentralized perpetual exchange, with investors closely watching its institutional volume growth and the potential for a broader market rotation into perp-DEX platforms.

Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.

Inventiva - ADR

Inventiva is attracting investor attention following the initiation of coverage by several analysts with buy ratings, fueling discussions about the potential of its lead asset, lanifibranor, in the MASH market. Community members are actively debating the company's valuation gap compared to sector peers and its long-term prospects as a potential acquisition target for larger pharmaceutical firms.

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.

Adaptive Biotechnologies Corp

Adaptive Biotechnologies is seeing significant investor interest driven by a substantial revenue beat in its preliminary financial results, bolstered by strong performance in its clonoSEQ MRD testing segment. The community is actively discussing the company's valuation, its potential as a takeover target, and its operational progress as it continues to expand its footprint in immuno-oncology.

Golar LNG Ltd. owns and operates liquefied natural gas carriers, floating storage, and regasification unit. It operates through the following segments: Vessel Operations, FLNG, and Power. The Vessel Operations segment operates and charter out vessels on fixed terms to customers. The FLNG segment provides integrated upstream and midstream solution for the development of gas reserves to LNG. The Power segment integrated LNG based downstream solutions, through the ownership and operation of FSRUs and associated terminal and power generation infrastructure. The company was founded on May 10, 2001 and is headquartered in Hamilton, Bermuda.

Golar Lng

Golar LNG is trending as investors bet on the company's critical role in the global energy supply chain, specifically through its floating liquefaction infrastructure amid ongoing geopolitical tensions and tight supply constraints. Market participants are actively discussing the stock's potential to capitalize on long-term project backlogs and the broader structural shift toward mobile, reliable energy export solutions.

Cenovus Energy, Inc. is a Canadian-based integrated energy company, which engages in the provision of gas and oil. It operates through the following segments: Upstream, Downstream, and Corporate and Eliminations. The Upstream segment refers to operations of oil sands, conventional, and offshore. The Downstream segment operates the Canadian and U.S. refining. The Corporate and Eliminations segment includes the corporates costs for general and administrative. The company was founded in 1881 and is headquartered in Calgary, Canada.

Cenovus Energy Inc

Cenovus Energy is trending as investors weigh strong production growth and operational efficiency against geopolitical uncertainties that are tightening global oil supply. The community is actively debating the company's valuation, recent share buyback activity, and the long-term strategic benefits of expanding pipeline capacity to reach new export markets.

Franco-Nevada Corp. engages in the management of gold-focused royalties and streams portfolio. It provides investors with gold price and exploration optionality while limiting exposure to many of the risks of operating companies. The company was founded in 1983 and is headquartered in Toronto, Canada.

Franco-Nevada Corporation

Franco-Nevada is currently drawing investor attention due to its strong balance sheet and debt-free status, which positions the royalty powerhouse to capitalize on record-setting gold and silver prices. Community discussion highlights the company's resilient business model compared to traditional miners, while also closely monitoring the potential upside from the Cobre Panama project and strategic royalty acquisitions.

Direxion Shares ETF Trust - Direxion Daily Junior Gold Miners Index Bull 2X ETF

Direxion Daily Junior Gold Miners Index Bull 2X Shares

JNUG is trending as investors capitalize on surging gold prices and heightened market volatility, with the community actively debating whether the current price action signals a sustainable long-term breakout or an overextended blow-off top. The conversation is dominated by contrasting views on whether to continue riding the momentum in mining ETFs or prepare for a significant pullback as broader macro concerns like deficit spending and central bank policies remain central to the bullish sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Aura Biosciences (AURA) Outperforming Other Medical Stocks This Year?

Here is how Aura Biosciences, Inc. (AURA) and Elicio Therapeutics (ELTX) have performed compared to their sector so far this year.

Aura Biosciences (AURA) to Release Earnings on Monday

Aura Biosciences (NASDAQ:AURA) will be releasing its Q4 2025 earnings before the market opens on Monday, March 23. (View Earnings Report at...

Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Update

Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) saw a significant drop in short interest during the month of February. As of February 27th, there was short interest totaling 2,249,277 shares...

Aura Biosciences Touts Phase 3 bel-sar Momentum, Eyes Mid-Year Bladder Cancer Data at TD Cowen Conference

Aura Biosciences (NASDAQ:AURA) highlighted progress across its ocular oncology pipeline and provided updates on a parallel effort in bladder cancer during a fireside chat at TD Cowen's 46th Annual...

Is Assertio (ASRT) Outperforming Other Medical Stocks This Year?

Here is how Assertio (ASRT) and Aura Biosciences, Inc. (AURA) have performed compared to their sector so far this year.

Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Rating of "Moderate Buy" from Analysts

Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) has been given an average recommendation of "Moderate Buy" by the six analysts that are presently covering the firm, Marketbeat.com reports. One...

Insider Selling: Aura Biosciences (NASDAQ:AURA) Insider Sells 20,401 Shares of Stock

Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) insider Janet Jill Hopkins sold 20,401 shares of the company's stock in a transaction dated Tuesday, February 17th. The shares were sold at an...

Mark Plavsic Sells 15,890 Shares of Aura Biosciences (NASDAQ:AURA) Stock

Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) CTO Mark Plavsic sold 15,890 shares of the firm's stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price...

Aura Biosciences (NASDAQ:AURA) Insider Sells $103,229.06 in Stock

Aura Biosciences (NASDAQ:AURA) Insider Los Pinos Elisabet De Sells 47,648 Shares

Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) insider Los Pinos Elisabet De sold 47,648 shares of the business's stock in a transaction that occurred on Tuesday, February 17th. The stock was...

Aura Biosciences, Inc. is a clinical-stage oncology company, which engages in developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity. The firm's product candidate belzupacap sarotalocan (AU-011) is in Phase 2 development for the first line treatment of choroidal melanoma, a vision and life-threatening form of eye cancer where standard of care radioactive treatments leave patients with major vision loss and severe comorbidities. The was founded by Elisabet de los Pinos in 2007 and is headquartered in Boston, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.43	--	--	N/A
Q3 '25	-$0.46	-$0.40	13.79%	BEAT
Q2 '25	-$0.48	-$0.47	1.67%	BEAT
Q1 '25	-$0.49	-$0.55	-12.03%	MISSED
Q4 '24	-$0.44	-$0.52	-17.21%	MISSED

AURA
Aura Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest AURA News

AURAAura Biosciences Inc